New guidance has been published on managing diabetes in the elderly, including for the first time how to manage treatment for the particularly frail The guidance was produced from a collaboration between experts in diabetes medicine, primary care and geriatric medicine, led by Dr David Strain at the University of Exeter Medical School. It will...
Post
Insomnia is a likely long-term side effect of stroke
Stroke patients experience sustained problems with insomnia potentially reducing their ability to relearn key skills and putting them at increased risk of depression, a new study in the journal Scientific Reports finds. In the first study of its kind, researchers from the University of Surrey, University of Freiburg, Germany, and the University of Bern, Switzerland, conducted an...
Post
Sweet tooth? Brain-tinkering study makes sugar taste vile
Have you ever been on a diet and wished that spinach excited your tastebuds? Or that chocolate left you cold? Neural projections from the sweet (green) and bitter (red) cortex terminate at distinct targets in the amygdala in the brains of mice. Neuroscientists said Wednesday they have discovered how to manipulate the brain to make...
Post
Brain cancer vaccine effective in some patients
Most people with the deadly brain cancer glioblastoma die less than 18 months after diagnosis. But a multicenter clinical trial of a personalized vaccine that targets aggressive cancer has indicated improved survival rates for such patients. The study appears May 29 in the Journal of Translational Medicine. The phase three clinical trial included 331 patients at over 80 sites...
Post
‘RIGHT TO TRY’ LAW WILL GIVE TERMINALLY ILL PATIENTS ACCESS TO EXPERIMENTAL DRUGS
President Donald Trump on Wednesday signed a bill that will allow terminally ill patients to request experimental drugs that the Food and Drug Administration has not yet approved. “Our implementation of the Right to Try Act will build on our long-standing efforts to help patients and families who are facing life-threatening diseases or conditions, in a way...
Post
Study offers new hope for the fight against genetically determined obesity
UNIVERSITY OF COPENHAGEN THE FACULTY OF HEALTH AND MEDICAL SCIENCES Around two to six per cent of all people with obesity develop obesity already in early childhood; it’s in their genetic cards. Obesity-causal mutations in one of their ‘appetite genes’ gives them a strong genetic predisposition for developing obesity, also called monogenic obesity. Their experience...
Post
New telemedicine exercise therapy
Anyone who gets an artificial hip or knee joint has to spend a lot of time in rehabilitation. The offers are scarce, though, and working people often cannot make the appointments due to time constraints. The result: the therapy is delayed, there are additional costs, and there is the added risk of possible health restrictions....
Post
Nucleoside logic: Supply-side programming of the immune biocomputer
The immune system is host to a bewildering array of cell types. Traditionally, immunologists have classified cells in different states of activation according to the various interleukins, interferons and other cytokines they express or secrete. Unfortunately, this ever-sprawling matrix of cell markers has become a matrix of exceptions that is rapidly collapsing under its own...
Post
Imec Develops Wireless Eye-Tracking Glasses to Aid in Research of Neurological Disorders
Many neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, can often present with symptoms of abnormal eye movements. Much research has been done in utilizing eye movement tracking technology to help with the diagnosis of these diseases and the monitoring of their progression. Traditional eye-tracking technology relies heavily on cameras, which, while accurate, are typically large...
Post
Growth hormone may provide new hope for stroke survivors
Less fatigue and better recovery of cognitive abilities such as learning and memory. These may be the results of growth hormone treatment after a stroke, an experimental study of mice published in the journal Stroke suggests. IMAGE: JORGEN ISGAARD, PROFESSOR, SAHLGRENSKA ACADEMY, UNIVERSITY OF GOTHENBURG, SWEDEN, AND UNIVERSITY OF NEWCASTLE, AUSTRALIA. “We hope that this work can pave...